Cart
sales@molnova.com
para-Nitroblebbistatin
CAS No. 1621326-32-6
para-Nitroblebbistatin( —— )
Catalog No. M33054 CAS No. 1621326-32-6
para-Nitroblebbistatin is a non-cytotoxic, non-fluorescent, photostable, and specific inhibitor of myosin II.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 135 | Get Quote |
|
| 5MG | 212 | Get Quote |
|
| 10MG | 316 | Get Quote |
|
| 25MG | 495 | Get Quote |
|
| 50MG | 673 | Get Quote |
|
| 100MG | 891 | Get Quote |
|
| 200MG | 1197 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Namepara-Nitroblebbistatin
-
NoteResearch use only, not for human use.
-
Brief Descriptionpara-Nitroblebbistatin is a non-cytotoxic, non-fluorescent, photostable, and specific inhibitor of myosin II.
-
Descriptionpara-Nitroblebbistatin is a non-cytotoxic, photostable, fluorescent and specific Myosin II inhibitor, usd in the study of the specific role of myosin II in physiological, developmental, and cell biological studies.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMyosin
-
RecptorMyosin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1621326-32-6
-
Formula Weight337.33
-
Molecular FormulaC18H15N3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 22 mg/mL (65.22 mM; Ultrasonic (<60°C)
-
SMILESCc1ccc2N=C3N(CC[C@@]3(O)C(=O)c2c1)c1ccc(cc1)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Képiró M, et al. para-Nitroblebbistatin, the non-cytotoxic and photostable myosin?II inhibitor. Angew Chem Int Ed Engl. 2014 Jul 28;53(31):8211-5.?
molnova catalog
related products
-
Mavacamten
Mavacamten (SAR-439152, MYK-461) is a small molecule that reduces contractility by decreasing the ATPase activity of the cardiac myosin heavy chain.
-
Danicamtiv
Danicamtiv is an inotropic agent and it also is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.
-
JB002
JB002, a myosin II inhibitor, exhibits potent activity with an IC50 of ≤10 μM. It holds potential for research applications in muscle spasticity, chronic musculoskeletal pain, and hypertrophic cardiomyopathy.
